Fed’s Warsh Signals Rate Hike; SpaceX Retail Surge

This week’s healthcare deal flow from the trade feeds is thin on named practice acquisitions, but one notable funding event stands out for the behavioral-health sector.

InStride Health closes $30M Series C. InStride Health is a pediatric mental health company. It has raised $30 million in a Series C round to scale its services. The round drew new investors Echo Health Ventures and FMZ Ventures. Existing backers .406 Ventures, Valtruis, General Catalyst, and Mass General Brigham Ventures also joined. No valuation or revenue figures were disclosed. The raise signals continued private-capital appetite for behavioral-health platforms targeting younger patients. That segment has attracted sustained DSO- and MSO-style roll-up interest from larger platforms looking for add-on targets.

Markets face a week defined by a more hawkish Federal Reserve, a geopolitically significant U.S.-Iran agreement, and a high-profile retail-investor driven market debut — all landing simultaneously.

Fed holds rates, removes cutting bias, signals possible hike. The Federal Reserve held its benchmark rate steady at its June meeting. However, new Chair Kevin Warsh dramatically rewrote the policy statement to strip out any easing bias. The median Fed projection now calls for the federal funds rate to end 2026 at 3.8%. That is a quarter percentage point above the current target range, which implies at least one hike this year. Warsh withheld his own individual rate forecast, or “dot,” from the Summary of Economic Projections. In effect, he declined to provide forward guidance at his first meeting as chair. Futures markets responded by pricing in higher borrowing costs. Bond investor Jeffrey Gundlach characterized Warsh as definitively not the “easy money” chairman many had anticipated. He argued the stance reduces the risk of overly accommodative policy reigniting inflation.

U.S. and Iran sign MOU; Strait of Hormuz to reopen. The United States and Iran signed a memorandum of understanding this week. President Trump confirmed his signature on the agreement. Under the deal’s terms, Iran will reopen the Strait of Hormuz and the U.S. will lift its naval blockade. In exchange, Iran stands to receive sanctions relief to sell oil. Further relief, including access to frozen funds, would depend on future negotiations over its nuclear program. The signing was originally scheduled for Friday in Switzerland, but it was accelerated. Israeli Prime Minister Netanyahu reacted with fury, having been caught by surprise when Trump announced the deal. Israeli officials said they had not been permitted to review the MOU’s text. U.S. gas prices fell below $4 per gallon after the announcement. Still, British officials and Bank of England policymakers cautioned that inflation would linger. They kept UK interest rates on hold, citing continued uncertainty from the conflict’s economic aftermath.

SpaceX trading debut draws retail investor wave. SpaceX’s blockbuster stock market debut became a flashpoint for the growing influence of individual retail investors. The company has rapidly become one of the world’s most valuable businesses. Michael Burry said publicly he was tempted to bet against SpaceX, given its market capitalization relative to established companies. However, he ultimately passed, citing the cost of options. Financial advisers publicly cautioned individual buyers about the risks of concentrated single-stock exposure.

G7 wraps; China presses AI governance. The G7 summit concluded without Chinese participation. Even so, Beijing used the occasion to publish a global governance whitepaper foregrounding artificial intelligence safety. It also announced accelerated international cooperation efforts. The move positions China as an active voice in shaping global AI norms ahead of anticipated multilateral frameworks.